Esperion Therapeutics Inc (ESPR)

Income Before Tax

-$5.58M

TTM · Period ending: · USD

ESPR logo

ESPR Income Before Tax

Latest reported-$5.58M
ESPR TTM Pre-Tax Income (-$31.59M → -$5.58M)
High-resolution chart · PNG

ESPR income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Esperion Therapeutics Inc Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-5,582,000
-20,841,000
-105,831,000
-104,022,000
-153,222,000
-51,745,000
-86,771,000
-98,497,000
-86,507,000
-209,248,000
-208,391,000
-222,258,000
-238,647,000
-233,659,000
-243,291,000
-257,560,000
-234,904,000
-269,108,000
-308,465,000
-324,516,000
-156,237,000
-143,551,000
-101,021,000
-83,961,000
-262,793,000
-97,165,000
-95,258,000
-76,792,000
-68,301,000
-201,810,000
-179,662,000
-174,970,000
-172,577,000
-166,988,000
-158,053,000
-130,236,000
-100,934,000
-74,978,000
-59,144,000
-54,543,000
-52,903,000
-49,784,000
-46,119,000
-43,124,000
-39,967,000
-36,375,000
-36,607,446
-32,039,880
-29,722,956
-26,088,133
-19,174,043
-17,286,883
-13,531,961
-11,741,736
-15,529,380
-20,613,106
-24,852,952
-29,023,000
-29,440,000
-28,829,000
-28,726,000
-28,451,000
-27,752,000
-26,253,000
-24,931,000
-25,390,000
-30,802,000
-31,848,000
-31,592,392
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.